| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/20/2002 | EP1180141A2 The p2x 3 receptor, methods of altering p2x 3receptor activity and uses thereof |
| 02/20/2002 | EP1180138A1 A polynucleotide motor, a motor system, their preparation and uses |
| 02/20/2002 | EP1180118A1 Fimbrial proteins |
| 02/20/2002 | EP1180117A1 Models of prion disease |
| 02/20/2002 | EP1180112A1 Detection using degradation of a tagged sequence |
| 02/20/2002 | EP1180111A1 Method and apparatus for compound library preparation using optical modulator |
| 02/20/2002 | EP1056528A4 Method for high resolution liquid chromatographic separation of polynucleotides |
| 02/20/2002 | EP0964704B1 Compositions for nucleic acid targeting |
| 02/20/2002 | EP0958252B1 Methods for the detoxification of nitrile and/or amide compounds |
| 02/20/2002 | EP0874992B1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 02/20/2002 | EP0863994B1 Multi-zone sterility indicator |
| 02/20/2002 | CN2478098Y Dehydrogenase active analyzer |
| 02/20/2002 | CN1337005A Cholesterol sensor and method for determining cholesterol |
| 02/20/2002 | CN1336960A DNA sequencing method which employs various DNA polymerases and kit used for the same |
| 02/20/2002 | CN1336959A Method for introducing substances into cells and use of said method |
| 02/20/2002 | CN1336957A BASB006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/20/2002 | CN1336935A Compositions and methods for WT1 specific immunotherapy |
| 02/20/2002 | CN1336440A Cross chain reaction |
| 02/20/2002 | CN1336439A Non-labeled biochip |
| 02/20/2002 | CN1079435C Method for preparing human red blood cell culture medium |
| 02/20/2002 | CN1079432C Enzyme prepn. special for enzyme washing textile products and its preparing method |
| 02/19/2002 | US6348596 Non-fluorescent asymmetric cyanine dye compounds useful for quenching reporter dyes |
| 02/19/2002 | US6348588 Method of cleaving a nucleic acid bulge |
| 02/19/2002 | US6348586 Nucleotide sequence of herpes virus; diagnosis; vaccines; viricides; antisense agents; triplex oligonucleotides; |
| 02/19/2002 | US6348582 Prokaryotic polynucleotides polypeptides and their uses |
| 02/19/2002 | US6348579 FtsL |
| 02/19/2002 | US6348578 Apt |
| 02/19/2002 | US6348570 Tetrapeptides; diagnosing and monitoring inflammatory, nervous system, skin, cardiovascular, respiratory system, gastrointestinal, urogenital and immune disorders; evaluating inhibitors |
| 02/19/2002 | US6348486 Methods for modulating bladder function |
| 02/19/2002 | US6348342 Compounds |
| 02/19/2002 | US6348340 Compounds |
| 02/19/2002 | US6348336 Process for purification of PCR test samples |
| 02/19/2002 | US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences |
| 02/19/2002 | US6348324 Thiazole esters which are hydrolyzed upon exposure to leukocytes in urine and can then react with diazonium salts to produce azo dyes |
| 02/19/2002 | US6348319 Enzyme detection biosensors |
| 02/19/2002 | US6348317 Fluorescent and DNA cleavage properties of peptide/dye conjugates |
| 02/19/2002 | US6348316 Genetic testing for determining the risk of pouchitis development |
| 02/19/2002 | US6348314 Invasive cleavage of nucleic acids |
| 02/19/2002 | US6348313 Sequentially removing bases from nucleic acid in predetermined numbers, with product remaining from each step being ligated to labelled adapter specific for bases and including oligonucleotide sequence comprising predetermined bases |
| 02/19/2002 | US6348311 Determining extent of htlv integration in presence of potential inhibitor of ataxia telangiectasia-mutated mediated kinase activity, wherein absence of integration indicates inhibition |
| 02/19/2002 | US6348310 Quantitation of individual protein kinase activity |
| 02/19/2002 | CA2141060C Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods |
| 02/18/2002 | CA2354653A1 Peptide mutant of human erab/hadh2, its x-ray crystal structure, and materials and method for identification of inhibitors thereof |
| 02/14/2002 | WO2002013122A2 System and method for characterising and sequencing polymers |
| 02/14/2002 | WO2002012902A2 Split-ubiquitin based reporter systems and methods of their use |
| 02/14/2002 | WO2002012901A2 Use of grf1 protein for screening molecules |
| 02/14/2002 | WO2002012900A1 Identification of viral agents in breast ducts and antiviral therapy therefore |
| 02/14/2002 | WO2002012896A1 Methods for manipulating moieties in microfluidic systems |
| 02/14/2002 | WO2002012894A1 Kruppel-like factor 6 (klf6), a tumorsuppressor protein, and dia gnostics, therapeutics, and screening based on this protein |
| 02/14/2002 | WO2002012893A2 Microarrays of functional biomolecules, and uses therefor |
| 02/14/2002 | WO2002012891A1 Substrate activation kit and method of detecting dna or the like by using the same |
| 02/14/2002 | WO2002012881A1 Rapid papanicolaou staining method for cervico-vaginal specimens |
| 02/14/2002 | WO2002012855A2 Method and system for rapid biomolecular recognition of amino acids and protein sequencing |
| 02/14/2002 | WO2002012854A2 Systems and methods for providing information concerning chromophores in physiological media |
| 02/14/2002 | WO2002012568A2 Cell-based analysis of high throughput screening data for drug discovery |
| 02/14/2002 | WO2002012567A1 Vhl promoter diagnostic polymorphism |
| 02/14/2002 | WO2002012566A2 The use and evaluation of a [2+2] photocycloaddition in immobilization of oligonucleotides on a three-dimensional hydrogel matrix |
| 02/14/2002 | WO2002012565A1 Association of sim2 with cancer |
| 02/14/2002 | WO2002012564A2 Methods for identifying low-abundance polynucleotides and related compositions |
| 02/14/2002 | WO2002012563A2 Detection and diagnosis of smoking related cancers |
| 02/14/2002 | WO2002012562A2 Haplotypes of the pla2g1b gene |
| 02/14/2002 | WO2002012561A2 Haplotypes of the or1g1 gene |
| 02/14/2002 | WO2002012560A1 Method of amplifying nucleic acids of microorganisms present in fruit juice |
| 02/14/2002 | WO2002012559A1 Kits for extracting nucleic acid and method of extracting nucleic acid by using the kits |
| 02/14/2002 | WO2002012557A1 Method for detecting known mutations in tube |
| 02/14/2002 | WO2002012556A1 Screening of a novel hepatic syndrome and its uses |
| 02/14/2002 | WO2002012555A2 Means for targeting nucleic acid repeat regions |
| 02/14/2002 | WO2002012554A2 Diagnosis of diseases which are associated with cd24 |
| 02/14/2002 | WO2002012551A2 Map-based genome mining method for identifying gene regulatory loci |
| 02/14/2002 | WO2002012550A1 Composite amperometric biosensor for determining cholesterol in foodstuffs |
| 02/14/2002 | WO2002012549A1 Compositions and methods for detecting and quantifying cox-2 activity and 2-arachidonylglycerol metabolites |
| 02/14/2002 | WO2002012547A1 Multiplexed enzymatic assays |
| 02/14/2002 | WO2002012546A2 Biosensor arrays and methods |
| 02/14/2002 | WO2002012544A2 Identification of short chain dehydrogenases/reductases (sdr) |
| 02/14/2002 | WO2002012542A2 Enzyme substrate |
| 02/14/2002 | WO2002012541A2 Novel motor proteins and methods for their use |
| 02/14/2002 | WO2002012538A2 Nucleic acids and pathogenic e.coli proteins, and their uses |
| 02/14/2002 | WO2002012515A1 Assays for alternative lengthening of telomeres |
| 02/14/2002 | WO2002012506A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 02/14/2002 | WO2002012499A2 Haplotypes of the ntf3 gene |
| 02/14/2002 | WO2002012498A2 Haplotypes of the isl1 gene |
| 02/14/2002 | WO2002012497A2 Haplotypes of the nfkbib gene |
| 02/14/2002 | WO2002012470A2 A member of the lysyl oxidase gene family |
| 02/14/2002 | WO2002012467A2 Drug metabolizing enzymes |
| 02/14/2002 | WO2002012461A2 Regulation of human membrane-type serine protease |
| 02/14/2002 | WO2002012456A2 Ampk-related serine/threonine kinase, designated snark |
| 02/14/2002 | WO2002012448A1 Methods for culturing human lung mast cells and uses thereof |
| 02/14/2002 | WO2002012447A2 Isolation and use of solid tumor stem cells |
| 02/14/2002 | WO2002012445A1 Detection of cox-2 activity and anandamide metabolites |
| 02/14/2002 | WO2002012440A2 Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles |
| 02/14/2002 | WO2002012434A2 A global electronic medicine response profile testing network |
| 02/14/2002 | WO2002012342A2 Haplotypes of the edg4 gene |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012339A2 Sequences for integrin alpha-8 |
| 02/14/2002 | WO2002012326A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | WO2002012325A2 Suppressor gene |
| 02/14/2002 | WO2002012290A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 02/14/2002 | WO2002012284A2 Iron regulating protein-2 (irp-2) as a diagnostic for neurodegenerative disease |
| 02/14/2002 | WO2002012279A2 Schizophrenia related gene and protein |
| 02/14/2002 | WO2002012275A2 Lat peptides and their use in assays for identifying immunosuppressants |